Drugs · acquisition-cost intelligence
heparin sodium
· ingredient heparinHeparins or heparinoids for topical use· HEPARIN SODIUM 10000 [USP'U]/mL; HEPARIN SODIUM 1000 [USP'U]/mL; HEPARIN SODIUM 20000 [USP'U]/mL; HEPARIN SODIUM 5000 [USP'U]/.5mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$1.16
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 7 weeks.
2025-07-232026-05-20
Same-ingredient options by acquisition cost
Other heparin products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Heparin Sodium | $1.16 | +$0.00000 |
| Heparin Sodium | $3.56 | +$2.40 |
| Heparin Sodium | $5.90 | +$4.74 |
Medicare Part D coverage · CY2026
On 297 plan formularies · typical tier 3
Prior auth 28% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.